Pragmatic Kappos brings USPTO claims and continuations litigation to an end
You can file this away in the "It should have happened a long time ago" file. Yesterday GlaxoSmithKline and the US Patent and Trademark Office announced that they would be submitting a motion to dismiss litigation concerning the controversial claims…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.